美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

VanEck Healthcare TruSector ETF

28.87

-0.0429-0.15%

盤後：28.80-0.0659-0.23%16:10 EDT

成交量：262

成交額：7,566

市值：57.73萬

市盈率：- -

高：28.87

開：28.80

低：28.80

收：28.91

52周最高：30.68

52周最低：24.78

股本：2.00萬

流通股本：2.00萬

量比：0.28

換手率：1.31%

股息：0.08

股息率：0.29%

淨資產收益率：--

總資產收益率：--

市淨率：--

市盈率(LYR):- -

資料載入中...

總覽公司新聞公告

概念

no data

沒有相關數據

資金流向

資金流入：

資金流出：

新聞

強生Rybrevant聯合化療在EGFR外顯子20插入突變非小細胞肺癌中實現迄今報告最長的中位總生存期

強生：RYBREVANT聯合化療在EGFR外顯子20插入突變非小細胞肺癌中實現已報告的最長中位總生存期。

強生據報與阿波羅洽談約200億美元骨科業務交易

环球市场播报

傳阿波羅(APO.US)擬接盤強生(JNJ.US)骨科業務潛在交易估值近200億美元

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrcrest.com/hant/stock/TRUH"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"TRUH","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TRUH\",,,,,undefined,":{"symbol":"TRUH","market":"US","secType":"STK","nameCN":"VanEck Healthcare TruSector ETF","latestPrice":28.8659,"timestamp":1789156800000,"preClose":28.9088,"halted":0,"volume":262,"hourTrading":{"tag":"盘后","latestPrice":28.8,"preClose":28.8659,"latestTime":"16:10 EDT","volume":6,"amount":173.1036,"timestamp":1789157404921,"change":-0.0659,"changeRate":-0.002283,"amplitude":0},"delay":0,"changeRate":-0.0014839771972547976,"floatShares":20000,"shares":20000,"eps":0,"marketStatus":"未開盤","change":-0.0429,"latestTime":"09-11 16:00:00 EDT","open":28.8,"high":28.8659,"low":28.8,"amount":7566,"amplitude":0.00228,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1789372800000},"marketStatusCode":0,"adr":0,"exchange":"NASDAQ","adjPreClose":28.9088,"nav":28.85268,"aum":577053.53,"dividendRate":0.002896,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":28.8,"preClose":28.8659,"latestTime":"16:10 EDT","volume":6,"amount":173.1036,"timestamp":1789157404921,"change":-0.0659,"changeRate":-0.002283,"amplitude":0},"volumeRatio":0.2819022934612989},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TRUH\",,,,,undefined,":{"symbol":"TRUH","floatShares":20000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.2819022934612989,"shares":20000,"dividePrice":0.0836,"high":28.8659,"amplitude":0.00228,"preClose":28.9088,"low":28.8,"week52Low":24.78,"pbRate":"--","week52High":30.68,"institutionHeld":0,"latestPrice":28.8659,"eps":0,"divideRate":0.002896,"volume":262,"delay":0,"ttmEps":0,"open":28.8,"prevYearClose":25.65,"prevWeekClose":29.8944,"prevMonthClose":29.7656,"prevQuarterClose":27.7644,"fiveDayClose":30.2197,"twentyDayClose":29.3706,"sixtyDayClose":26.6574},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/TRUH\",params:#limit:5,,,undefined,":[{"date":"2026-07-01","symbol":"TRUH","amount":0.0847,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-07-01","defaultRemindTime":1782912600000,"name":"VanEck Healthcare TruSector ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-07-07","payableDate":"2026-07-01","currency":"USD","dateTimestamp":1782878400000,"payDate":"2026-07-07"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"TRUH\",market:\"US\",,,undefined,":[{"executeDate":"2026-07-01","recordDate":"2026-07-01","paymentDate":"2026-07-07","value":0.0847,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"TRUH\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"TRUH\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1120093998","title":"強生Rybrevant聯合化療在EGFR外顯子20插入突變非小細胞肺癌中實現迄今報告最長的中位總生存期","url":"https://stock-news.laohu8.com/highlight/detail?id=1120093998","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1120093998?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 09:47","pubTimestamp":1789350464,"startTime":"0","endTime":"0","summary":"强生公司日前公布了一项重磅临床数据——其旗下药物Rybrevant与化疗联用，在携带EGFR外显子20插入突变的非小细胞肺癌患者中，取得了目前公开报告中最长的中位总生存期。EGFR外显子20插入突变，历来被视为治疗难点，可选方案有限且疗效欠佳。观察人士指出，这不仅能巩固Rybrevant在精准医疗版图中的地位，更可能重塑晚期非小细胞肺癌的一线治疗格局。强生能否借此在竞争激烈的肺癌药物市场中进一步扩大优势，值得持续跟踪。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0289739343.SGD","IE00BLSP4239.USD","LU0124676726.USD","LU1894683264.USD","LU2213496289.HKD","LU2896262040.SGD","LU2756315318.SGD","LU1506573853.SGD","IE00BFXG1179.USD","IE0001KFT4U8.USD","LU1674673428.USD","IE0002270589.USD","IE0002141913.USD","BK4007","LU1057294990.SGD","IE000BZT7R73.USD","LU1989771016.USD","IE000M9KFDE8.USD","LU0820561818.USD","LU1074936037.SGD","LU1267930813.SGD","LU2456880835.USD","LU2471134523.USD","RXL","IE00BFTCPJ56.SGD","LU2023250330.USD","SG9999001176.SGD","SG9999001176.USD","LU1145028129.USD","LU0098860793.USD","LU1023059063.AUD","LU1043141123.HKD","LU0053666078.USD","LU2430703251.USD","IE00B1BXHZ80.USD","GDOC","FTXH","LU0795875169.SGD","LU1244550577.SGD","LU1732800096.USD","BK4581","BK4534","IE00BVYPNW00.USD","LU0070217475.USD","LU1066051225.USD","LU0210528500.USD","LU2471134796.USD","MEDX","TRUH","LU0426417589.USD","LU0432979614.USD","LU0114720955.EUR","LU0964807845.USD","LU0511384066.AUD","LU1935042991.SGD","LU2505996681.GBP","LU1551013342.USD","LU2602419157.SGD","IE00B3T34201.USD","LU2750360641.GBP","LU1066051811.HKD","LU1228905540.USD","LU2487616109.SGD","LU1221951129.SGD","LU1228905037.USD","LU1291159041.SGD","LU0234572021.USD","IE00BN8TJ469.HKD","LU1496350502.SGD","IE00B19Z3581.USD","LU0289961442.SGD","LU0820562030.AUD","LU1778281490.HKD","LU1983299246.USD","LU0795875086.SGD","LU0345770308.USD","IHE","JDOC","IE000SO60NU8.SGD","LU1162221912.USD","LU2403377893.USD","BK4592","LU1585245621.USD","LU1121112475.USD","LU0426412945.USD","LU2129689605.HKD","LU1221951046.USD","LU1430594728.SGD","LU0203345920.USD","IE00B7SZLL34.SGD","LU2505996509.AUD","LU2129689514.USD","XLV","LU0994945656.USD","LU0162691827.USD","SG9999002232.USD","BK4550","LU0289739699.SGD","BK4559","LU1894683348.USD","IE0000B7K699.USD","LU2471134879.HKD","IE00B42XCP33.USD","LU0058720904.USD","LU1059921491.USD","LU0203347892.USD","IE00BVYPNV92.GBP","LU1043141396.HKD","BK4568","IE00BGHQF631.EUR","LU0234570918.USD","LU0683600562.USD","IE000WAW04H5.SGD","IE00B19Z3B42.SGD","IXJ","IE00BZ1G4Q59.USD","BK4504","LU0943347566.SGD","SGXZ80539844.SGD","LU2347655156.SGD","LU1061106388.HKD","LU0472753341.HKD","LU0057025933.USD","LU2236285917.USD","LU0820561909.HKD","VHT","LU0069063385.USD","LU0210536198.USD","LU0985320562.USD","LU1914381329.SGD","SG9999001440.SGD","LU2089984988.USD","BK4585","LU2750360997.AUD","IE0009355771.USD","IE00BJT1NW94.SGD","IE00B2B36J28.USD","IE00BKVL7J92.USD","LU0320765646.SGD","LU2133065610.SGD","IE00BDGV0183.EUR","LU1244550494.USD","IE00B3PB1722.GBP","IYH","BK4533","LU2430703095.HKD","LU1066053197.SGD","LU0072461881.USD","LU0122379950.USD","LU2129689431.USD","LU1244550221.USD","IE000MB6IJN5.SGD","LU1929549753.HKD","JNJ","LU1718418525.SGD","LU0889566641.SGD","LU1032955483.USD","LU1196500208.SGD","LU1280957306.USD","PJP","IE000F7OJYX1.SGD","LU0689472784.USD","SG9999002224.SGD","LU1674673691.USD","LU1261432733.SGD","BMED","LU2468319806.SGD","LU2756315664.SGD","LU0689626769.HKD","LU2471134952.CNY","SG9999013999.USD","LU1032466523.USD","IE00BSNM7G36.USD","LU0792757196.USD","LU0912757837.SGD","IE00BBT3K403.USD","LU1551013425.SGD","LU2112291526.USD","LU2417539215.USD","IE00B4R5TH58.HKD","IE00BLSP4452.SGD","LU0545562505.USD","FHLC","IE00BJJMRZ35.SGD","LU0640476718.USD","SGXZ57979304.SGD","LU0787776722.HKD","IE0034235303.USD","LU0345770993.USD","BK4532","LU0345769128.USD","LU0882574055.USD","LU2430703178.SGD","LU2592432038.USD","LU1732799900.SGD","LU0345769631.USD","BK4588","LU1066051498.USD","LU0466842654.USD","LU1629891620.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667631840","title":"強生：RYBREVANT聯合化療在EGFR外顯子20插入突變非小細胞肺癌中實現已報告的最長中位總生存期。","url":"https://stock-news.laohu8.com/highlight/detail?id=2667631840","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667631840?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 09:46","pubTimestamp":1789350398,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IE00BLSP4239.USD","LU1894683264.USD","IHE","JDOC","IE0001KFT4U8.USD","IE0002141913.USD","LU1280957306.USD","PJP","LU0820561909.HKD","VHT","LU1674673691.USD","LU0985320562.USD","LU2089984988.USD","BMED","LU2471134523.USD","RXL","IE00BFTCPJ56.SGD","LU1032466523.USD","LU1145028129.USD","LU0053666078.USD","GDOC","FTXH","XLV","FHLC","BK4550","LU2133065610.SGD","IE00BDGV0183.EUR","BK4559","LU1244550494.USD","IE0000B7K699.USD","IYH","BK4533","LU2430703095.HKD","MEDX","LU0426417589.USD","TRUH","LU2471134879.HKD","LU2592432038.USD","LU0072461881.USD","LU0122379950.USD","LU0511384066.AUD","IE00BVYPNV92.GBP","LU1935042991.SGD","BK4568","IE00B3T34201.USD","IE00BGHQF631.EUR","LU0683600562.USD","BK4588","JNJ","IXJ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667329689","title":"強生據報與阿波羅洽談約200億美元骨科業務交易","url":"https://stock-news.laohu8.com/highlight/detail?id=2667329689","media":"环球市场播报","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667329689?lang=zh_tw&edition=fundamental","pubTime":"2026-09-13 14:27","pubTimestamp":1789280820,"startTime":"0","endTime":"0","summary":"据知情人士消息，阿波罗全球管理公司正洽谈收购强生旗下以DePuy Synthes为主体的骨科业务，交易金额约为200亿美元。知情人士称，强生与阿波罗正在就出售展开谈判，但双方仍可能无法达成交易，强生也可能选择其他买家。强生和阿波罗目前均未公布交易安排。以当前报道的约200亿美元交易金额计算，潜在售价与强生当年的实际收购价格大致相当，但期间业务范围、财务表现和资产构成已经发生变化。此次潜在出售也是强生持续调整业务组合的一部分。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-09-13/doc-inirskha4546532.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["VHT","LU1228905540.USD","LU2896262040.SGD","XLV","RXL","LU1496350502.SGD","IE000F7OJYX1.SGD","PJP","LU0795875169.SGD","FHLC","LU2213496289.HKD","JDOC","LU2023250330.USD","JNJ","LU0122379950.USD","IE0009355771.USD","BMED","LU0889566641.SGD","LU1074936037.SGD","LU1732800096.USD","LU0057025933.USD","LU2089984988.USD","LU2456880835.USD","LU1066053197.SGD","LU2430703251.USD","LU2471134523.USD","IXJ","IE00BFXG1179.USD","IYH","LU0545562505.USD","LU1430594728.SGD","MEDX","IHE","LU0792757196.USD","LU0640476718.USD","LU2129689431.USD","LU0689472784.USD","LU1059921491.USD","IE00B42XCP33.USD","GDOC","FTXH","LU0426412945.USD","TRUH","LU1778281490.HKD","LU0795875086.SGD","IE00B19Z3581.USD","LU1935042991.SGD","LU0820561909.HKD","IE00BVYPNV92.GBP","IE00B4R5TH58.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666508051","title":"傳阿波羅(APO.US)擬接盤強生(JNJ.US)骨科業務 潛在交易估值近200億美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2666508051","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666508051?lang=zh_tw&edition=fundamental","pubTime":"2026-09-12 11:04","pubTimestamp":1789182275,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，据媒体援引知情人士消息报道，全球另类资产管理公司阿波罗全球管理 正洽谈收购强生的骨科业务部门DePuy Synthes。这笔交易对该业务的估值可能接近200亿美元。强生的骨科业务部门DePuy Synthes主要生产关节植入物和手术器械，2025年创造了93亿美元的收入，但收入增速仅为1.1%。相比之下，强生2025年整体营收同比增长6%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1495305.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU1244550494.USD","APO","LU0912757837.SGD","IYH","LU1989771016.USD","LU1066051498.USD","LU2471134523.USD","IE00BGHQF631.EUR","IE0001KFT4U8.USD","PRVT","LBO","LU0006061336.USD","TRUH","IE000BZT7R73.USD","LU2487616109.SGD","IE00B775SV38.USD","BK4585","XLV","IXJ","IHE","LU1506573853.SGD","LU1668664300.SGD","RXL","LU0689626769.HKD","LU0345769631.USD","IE00B42XCP33.USD","LU2756315318.SGD","IE000F7OJYX1.SGD","BMED","AAUM","LU2112291526.USD","LU1057294990.SGD","IE00B3T34201.USD","JNJ","LU1162221912.USD","VHT","PJP","MEDX","LU0545562505.USD","LU1032466523.USD","JDOC","LU2468319806.SGD","LU2129689431.USD","LU1267930813.SGD","LU2471134796.USD","GDOC","LU2602419157.SGD","GPZ","FTXH","FHLC"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":50,"pageCount":1,"totalSize":200,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/TRUH\",params:#limit:6,delay:false,,,undefined,":[]}}